InforLorV4, Main, Exploration, bibRecord, 000144

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Identifieur interne : 000144 ( Main/Exploration ); précédent : 000143; suivant : 000145

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Auteurs : M. Rondy [France] ; J. Castilla [Espagne] ; O. Launay [France] ; S. Costanzo [Italie] ; C. Ezpeleta [Espagne] ; F. Galtier [France] ; K. De Gaetano Donati [Italie] ; A. Moren [France]

Source :

Human vaccines & immunotherapeutics [ 2164-554X ] ; 2016.

RBID : pubmed:27065000

Abstract

We conducted a multicentre test negative case control study to estimate the 2013-14 influenza vaccine effectiveness (IVE) against hospitalised laboratory confirmed influenza in 12 hospitals in France, Italy and Spain. We included all ≥18 years hospitalised patients targeted by local influenza vaccination campaign reporting an influenza-like illness within 7 days before admission. We defined as cases patients RT-PCR positive for influenza and as controls those negative for all influenza virus. We used a logistic regression to calculate IVE adjusted for country, month of onset, chronic diseases and age. We included 104 A(H1N1)pdm09, 157 A(H3N2) cases and 585 controls. The adjusted IVE was 42.8% (95%CI: 6.3;65;0) against A(H1N1)pdm09. It was respectively 61.4% (95%CI: -1.9;85.4), 39.4% (95%CI: -32.2;72.2) and 19.7% (95%CI:-148.1;74.0) among patients aged 18-64, 65-79 and ≥80 years. The adjusted IVE against A(H3N2) was 38.1% (95%CI: 8.3;58.2) overall. It was respectively 7.8% (95%CI: -145.3;65.4), 25.6% (95%CI: -36.0;59.2) and 55.2% (95%CI: 15.4;76.3) among patients aged 18-64, 65-79 and ≥80 years. These results suggest a moderate and age varying effectiveness of the 2013-14 influenza vaccine to prevent hospitalised laboratory-confirmed influenza. While vaccination remains the most effective prevention measure, developing more immunogenic influenza vaccines is needed to prevent severe outcomes among target groups.

DOI: 10.1080/21645515.2015.1126013
PubMed: 27065000

Affiliations:

Espagne, France, Italie

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.</title>
<author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M" last="Rondy">M. Rondy</name>
<affiliation wicri:level="1"><nlm:affiliation>a Epicon0063ept , Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>a Epicon0063ept , Paris </wicri:regionArea>
<wicri:noRegion>Paris </wicri:noRegion>
<wicri:noRegion>Paris </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
<affiliation wicri:level="1"><nlm:affiliation>b Instituto de Salud Pública de Navarra, IdiSNA, CIBER Epidemiología y Salud Pública , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>b Instituto de Salud Pública de Navarra, IdiSNA, CIBER Epidemiología y Salud Pública </wicri:regionArea>
<wicri:noRegion>CIBER Epidemiología y Salud Pública </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O" last="Launay">O. Launay</name>
<affiliation wicri:level="1"><nlm:affiliation>c Inserm, CIC 1417 and F-CRIN, Innovative clinical research network in vaccinologie (I-REIVAC), Université Paris Descartes; Sorbonne Paris Cité ; Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>c Inserm, CIC 1417 and F-CRIN, Innovative clinical research network in vaccinologie (I-REIVAC), Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:regionArea>
<wicri:noRegion>Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:noRegion>
<wicri:noRegion>Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S" last="Costanzo">S. Costanzo</name>
<affiliation wicri:level="1"><nlm:affiliation>d Department of Epidemiology and Prevention , IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (Isernia) , Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>d Department of Epidemiology and Prevention , IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (Isernia) </wicri:regionArea>
<wicri:noRegion>Pozzilli (Isernia) </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C" last="Ezpeleta">C. Ezpeleta</name>
<affiliation wicri:level="1"><nlm:affiliation>e Service of Clinical Microbiology, Complejo Hospitalario de Navarra, IdiSNA , Pamplona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>e Service of Clinical Microbiology, Complejo Hospitalario de Navarra, IdiSNA , Pamplona </wicri:regionArea>
<wicri:noRegion>Pamplona </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F" last="Galtier">F. Galtier</name>
<affiliation wicri:level="1"><nlm:affiliation>f CHRU de Montpellier, Inserm, CIC 1411 and REIVAC , Montpellier , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>f CHRU de Montpellier, Inserm, CIC 1411 and REIVAC , Montpellier </wicri:regionArea>
<wicri:noRegion>Montpellier </wicri:noRegion>
<wicri:noRegion>Montpellier </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Gaetano Donati, K" sort="De Gaetano Donati, K" uniqKey="De Gaetano Donati K" first="K" last="De Gaetano Donati">K. De Gaetano Donati</name>
<affiliation wicri:level="1"><nlm:affiliation>g Department of Infectious Disease , Catholic University , Rome , Italy .</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>g Department of Infectious Disease , Catholic University , Rome </wicri:regionArea>
<wicri:noRegion>Rome </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moren, A" sort="Moren, A" uniqKey="Moren A" first="A" last="Moren">A. Moren</name>
<affiliation wicri:level="1"><nlm:affiliation>a Epicon0063ept , Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>a Epicon0063ept , Paris </wicri:regionArea>
<wicri:noRegion>Paris </wicri:noRegion>
<wicri:noRegion>Paris </wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="doi">10.1080/21645515.2015.1126013</idno>
<idno type="RBID">pubmed:27065000</idno>
<idno type="pmid">27065000</idno>
<idno type="wicri:Area/PubMed/Corpus">000007</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000007</idno>
<idno type="wicri:Area/PubMed/Curation">000007</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000007</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000013</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000013</idno>
<idno type="wicri:Area/Ncbi/Merge">000237</idno>
<idno type="wicri:Area/Ncbi/Curation">000229</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000229</idno>
<idno type="wicri:Area/Main/Merge">000130</idno>
<idno type="wicri:Area/Main/Curation">000144</idno>
<idno type="wicri:Area/Main/Exploration">000144</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.</title>
<author><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M" last="Rondy">M. Rondy</name>
<affiliation wicri:level="1"><nlm:affiliation>a Epicon0063ept , Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>a Epicon0063ept , Paris </wicri:regionArea>
<wicri:noRegion>Paris </wicri:noRegion>
<wicri:noRegion>Paris </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
<affiliation wicri:level="1"><nlm:affiliation>b Instituto de Salud Pública de Navarra, IdiSNA, CIBER Epidemiología y Salud Pública , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>b Instituto de Salud Pública de Navarra, IdiSNA, CIBER Epidemiología y Salud Pública </wicri:regionArea>
<wicri:noRegion>CIBER Epidemiología y Salud Pública </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O" last="Launay">O. Launay</name>
<affiliation wicri:level="1"><nlm:affiliation>c Inserm, CIC 1417 and F-CRIN, Innovative clinical research network in vaccinologie (I-REIVAC), Université Paris Descartes; Sorbonne Paris Cité ; Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>c Inserm, CIC 1417 and F-CRIN, Innovative clinical research network in vaccinologie (I-REIVAC), Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:regionArea>
<wicri:noRegion>Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:noRegion>
<wicri:noRegion>Université Paris Descartes; Sorbonne Paris Cité ; Paris </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S" last="Costanzo">S. Costanzo</name>
<affiliation wicri:level="1"><nlm:affiliation>d Department of Epidemiology and Prevention , IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (Isernia) , Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>d Department of Epidemiology and Prevention , IRCCS Istituto Neurologico Mediterraneo Neuromed, Pozzilli (Isernia) </wicri:regionArea>
<wicri:noRegion>Pozzilli (Isernia) </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C" last="Ezpeleta">C. Ezpeleta</name>
<affiliation wicri:level="1"><nlm:affiliation>e Service of Clinical Microbiology, Complejo Hospitalario de Navarra, IdiSNA , Pamplona , Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>e Service of Clinical Microbiology, Complejo Hospitalario de Navarra, IdiSNA , Pamplona </wicri:regionArea>
<wicri:noRegion>Pamplona </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F" last="Galtier">F. Galtier</name>
<affiliation wicri:level="1"><nlm:affiliation>f CHRU de Montpellier, Inserm, CIC 1411 and REIVAC , Montpellier , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>f CHRU de Montpellier, Inserm, CIC 1411 and REIVAC , Montpellier </wicri:regionArea>
<wicri:noRegion>Montpellier </wicri:noRegion>
<wicri:noRegion>Montpellier </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="De Gaetano Donati, K" sort="De Gaetano Donati, K" uniqKey="De Gaetano Donati K" first="K" last="De Gaetano Donati">K. De Gaetano Donati</name>
<affiliation wicri:level="1"><nlm:affiliation>g Department of Infectious Disease , Catholic University , Rome , Italy .</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>g Department of Infectious Disease , Catholic University , Rome </wicri:regionArea>
<wicri:noRegion>Rome </wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moren, A" sort="Moren, A" uniqKey="Moren A" first="A" last="Moren">A. Moren</name>
<affiliation wicri:level="1"><nlm:affiliation>a Epicon0063ept , Paris , France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>a Epicon0063ept , Paris </wicri:regionArea>
<wicri:noRegion>Paris </wicri:noRegion>
<wicri:noRegion>Paris </wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Human vaccines & immunotherapeutics</title>
<idno type="eISSN">2164-554X</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We conducted a multicentre test negative case control study to estimate the 2013-14 influenza vaccine effectiveness (IVE) against hospitalised laboratory confirmed influenza in 12 hospitals in France, Italy and Spain. We included all ≥18 years hospitalised patients targeted by local influenza vaccination campaign reporting an influenza-like illness within 7 days before admission. We defined as cases patients RT-PCR positive for influenza and as controls those negative for all influenza virus. We used a logistic regression to calculate IVE adjusted for country, month of onset, chronic diseases and age. We included 104 A(H1N1)pdm09, 157 A(H3N2) cases and 585 controls. The adjusted IVE was 42.8% (95%CI: 6.3;65;0) against A(H1N1)pdm09. It was respectively 61.4% (95%CI: -1.9;85.4), 39.4% (95%CI: -32.2;72.2) and 19.7% (95%CI:-148.1;74.0) among patients aged 18-64, 65-79 and ≥80 years. The adjusted IVE against A(H3N2) was 38.1% (95%CI: 8.3;58.2) overall. It was respectively 7.8% (95%CI: -145.3;65.4), 25.6% (95%CI: -36.0;59.2) and 55.2% (95%CI: 15.4;76.3) among patients aged 18-64, 65-79 and ≥80 years. These results suggest a moderate and age varying effectiveness of the 2013-14 influenza vaccine to prevent hospitalised laboratory-confirmed influenza. While vaccination remains the most effective prevention measure, developing more immunogenic influenza vaccines is needed to prevent severe outcomes among target groups.</div>
</front>
</TEI>
<affiliations><list><country><li>Espagne</li>
<li>France</li>
<li>Italie</li>
</country>
</list>
<tree><country name="France"><noRegion><name sortKey="Rondy, M" sort="Rondy, M" uniqKey="Rondy M" first="M" last="Rondy">M. Rondy</name>
</noRegion>
<name sortKey="Galtier, F" sort="Galtier, F" uniqKey="Galtier F" first="F" last="Galtier">F. Galtier</name>
<name sortKey="Launay, O" sort="Launay, O" uniqKey="Launay O" first="O" last="Launay">O. Launay</name>
<name sortKey="Moren, A" sort="Moren, A" uniqKey="Moren A" first="A" last="Moren">A. Moren</name>
</country>
<country name="Espagne"><noRegion><name sortKey="Castilla, J" sort="Castilla, J" uniqKey="Castilla J" first="J" last="Castilla">J. Castilla</name>
</noRegion>
<name sortKey="Ezpeleta, C" sort="Ezpeleta, C" uniqKey="Ezpeleta C" first="C" last="Ezpeleta">C. Ezpeleta</name>
</country>
<country name="Italie"><noRegion><name sortKey="Costanzo, S" sort="Costanzo, S" uniqKey="Costanzo S" first="S" last="Costanzo">S. Costanzo</name>
</noRegion>
<name sortKey="De Gaetano Donati, K" sort="De Gaetano Donati, K" uniqKey="De Gaetano Donati K" first="K" last="De Gaetano Donati">K. De Gaetano Donati</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/InforLorV4/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000144 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000144 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    InforLorV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:27065000
   |texte=   Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27065000" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a InforLorV4

This area was generated with Dilib version V0.6.33.
Data generation: Mon Jun 10 21:56:28 2019. Site generation: Fri Feb 25 15:29:27 2022

Serveur d'exploration sur la recherche en informatique en Lorraine

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur la recherche en informatique en Lorraine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.